{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:42:47Z","timestamp":1761100967357},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2351,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.bbmt.2008.09.003","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T09:00:59Z","timestamp":1224320459000},"page":"1298-1304","source":"Crossref","is-referenced-by-count":20,"title":["Successful Treatment of Stem Cell Graft Failure in Pediatric Patients Using a Submyeloablative Regimen of Campath-1H and Fludarabine"],"prefix":"10.1016","volume":"14","author":[{"given":"Nabil","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn S.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary D.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Carrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm K.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Krance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.09.003_bib1","first-page":"73","article-title":"Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation","volume":"14","author":"Davies","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1008259428364","article-title":"High-dose chemotherapy for chronic lymphocytic leukemia: eligibility, timing, and benefit?","volume":"9","author":"Khouri","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2008.09.003_bib3","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.09.003_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/00063030-200317030-00001","article-title":"T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation?","volume":"17","author":"Simpson","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.bbmt.2008.09.003_bib6","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-cell\u2013depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor\u2013mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib8","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.V99.7.2586","article-title":"Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution","volume":"99","author":"Klangsinsirikul","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/332323a0","article-title":"Reshaping human antibodies for therapy","volume":"332","author":"Riechmann","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2008.09.003_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V82.3.807.807","article-title":"Effect of Campath-1H antibody on human hematopoietic progenitors in vitro","volume":"82","author":"Gilleece","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib11","first-page":"183","article-title":"Ex-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype","volume":"2","author":"Wing","year":"1995","journal-title":"Ther Immunol"},{"key":"10.1016\/j.bbmt.2008.09.003_bib12","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1172\/JCI119110","article-title":"Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a\/CD18 (LFA-1) on NK cells","volume":"98","author":"Wing","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2008.09.003_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2567.1998.00615.x","article-title":"Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells","volume":"95","author":"Rowan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.bbmt.2008.09.003_bib14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V73.6.1431.1431","article-title":"Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype","volume":"73","author":"Dyer","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1705760","article-title":"Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation","volume":"40","author":"Jabbour","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bmt.1705730","article-title":"Reduced-intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood","volume":"40","author":"Strahm","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib17","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","article-title":"Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation","volume":"20","author":"Tsai","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1701918","article-title":"Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"24","author":"Ringden","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib20","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog\u2013containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog\u2013containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-2478(91)90204-N","article-title":"Mechanisms of graft failure after human marrow transplantation: a review","volume":"29","author":"Hows","year":"1991","journal-title":"Immunol Lett"},{"issue":"10","key":"10.1016\/j.bbmt.2008.09.003_bib23","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood.V98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bbmt.2007.07.006","article-title":"Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure","volume":"13","author":"Chewning","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib27","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V91.8.3079.3079_3079_3083","article-title":"Risks of developing Epstein-Barr virus\u2013related lymphoproliferative disorders after T-cell\u2013depleted marrow transplants. CAMPATH Users","volume":"91","author":"Hale","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.bbmt.2006.07.011","article-title":"Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia","volume":"12","author":"Kennedy-Nasser","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bmt.1704975","article-title":"CD52 and CD45 monoclonal antibodies for reduced-intensity hemopoietic stem cell transplantation from HLA-matched and one antigen-mismatched unrelated donors","volume":"35","author":"Popat","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705229","article-title":"Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)","volume":"37","author":"Popat","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib31","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1182\/blood.V96.7.2419","article-title":"In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation","volume":"96","author":"Kottaridis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.09.003_bib32","first-page":"235","article-title":"Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease","volume":"5","author":"Frassoni","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.09.003_bib33","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910800387X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387910800387X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:31:01Z","timestamp":1589027461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387910800387X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S108387910800387X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.09.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}